CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

A.O. Ayed, A. Chiappella, L. Pederson, B.R. Laplant, A.G. Congiu, G. Gaidano, M. Spina, A. Re, F. Cavallo, G. Musuraca, W.R. MacOn, T. Witzig, U. Vitolo, G.S. Nowakowski

Research output: Contribution to journalArticle

Cite this

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T., Vitolo, U., & Nowakowski, G. S. (2018). CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies. Blood Cancer Journal, 8(7). https://doi.org/10.1038/s41408-018-0097-0